Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bo Feldt-Rasmussen

Showing results (141-150 of 144) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 144 results.
Kidney International Reports|September 13, 2021
The Role of Vascular Lesions in Diabetes Across a Spectrum of Clinical Kidney DiseaseRosa Rodríguez-Rodríguez, Radovan Hojs, Francesco Trevisani, et al.
Cell Reports|November 9, 2017
Circulating Glucagon 1-61 Regulates Blood Glucose by Increasing Insulin Secretion and Hepatic Glucose ProductionNicolai J Wewer Albrechtsen, Rune E Kuhre, Daniel Hornburg, et al.
NEJM Evidence|October 28, 2025
Cardiac Effects of Dapagliflozin in People with Chronic Kidney DiseaseKatja Vu Bartholdy, Niklas Dyrby Johansen, Kristoffer Grundtvig Skaarup, et al.
Lancet (London, England)|June 14, 2011
The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trialColin Baigent, Martin J Landray, Christina Reith, et al.
Pageof 15

Showing results (141-150 of 144) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 144 results.
Kidney International Reports|September 13, 2021
The Role of Vascular Lesions in Diabetes Across a Spectrum of Clinical Kidney DiseaseRosa Rodríguez-Rodríguez, Radovan Hojs, Francesco Trevisani, et al.
Cell Reports|November 9, 2017
Circulating Glucagon 1-61 Regulates Blood Glucose by Increasing Insulin Secretion and Hepatic Glucose ProductionNicolai J Wewer Albrechtsen, Rune E Kuhre, Daniel Hornburg, et al.
NEJM Evidence|October 28, 2025
Cardiac Effects of Dapagliflozin in People with Chronic Kidney DiseaseKatja Vu Bartholdy, Niklas Dyrby Johansen, Kristoffer Grundtvig Skaarup, et al.
Lancet (London, England)|June 14, 2011
The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trialColin Baigent, Martin J Landray, Christina Reith, et al.
Pageof 15